Trials
Search / Trial NCT06423989

Role of Immunoglobulin in Male Infertility

Launched by DR SALMA KAFEEL QURESHI · May 16, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the role of a treatment called immunoglobulin (IVIG) in helping men who are having trouble with fertility, known as male subfertility. The researchers want to see if IVIG can improve certain aspects of semen quality and help with the success of assisted reproduction methods, like in vitro fertilization (IVF).

To take part in this study, participants must be male. The trial is currently recruiting, which means they are looking for volunteers. If you’re a man facing fertility issues, this might be an opportunity to explore a potential treatment. Participants will receive care related to the study, and they will help researchers understand if IVIG could be beneficial for men dealing with infertility.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • • male patients
  • Exclusion Criteria:
  • • female

About Dr Salma Kafeel Qureshi

Dr. Salma Kafeel Qureshi is a dedicated clinical trial sponsor with extensive experience in the field of medical research. With a strong focus on advancing healthcare through innovative clinical studies, Dr. Qureshi is committed to ensuring the highest standards of scientific integrity and patient safety. Her expertise spans a variety of therapeutic areas, enabling her to effectively oversee and manage complex trials from inception to completion. Dr. Qureshi's collaborative approach fosters strong partnerships with research institutions and regulatory bodies, ensuring that trials are conducted efficiently and ethically, ultimately contributing to the development of groundbreaking therapies and improved patient outcomes.

Locations

Islamabad, Capital, Pakistan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0